Fact CheckerSign in

NCT06106230Completed

Bee Venom Phonophoresis on Mild to Moderate Localized Plaque Psoriasis on Knee Joint

Source: ClinicalTrials.gov · Last updated 17 Apr 2024

Brief summary (registry, in English)

Chronic plaque psoriasis, or psoriasis vulgaris, is a chronic inflammatory skin disease characterized by well demarcated, erythematous, scaly plaques on the extensor surfaces of the body and scalp. The lesions may occasionally itch or sting, and may bleed when injured. Dystrophic nail changes or nail pitting are found in more than one third of people with chronic plaque psoriasis, and psoriatic arthropathy occurs in 1% to more than 10%. The condition waxes and wanes, with wide variations in course and severity among individuals.

Status (registry)
Completed
Study type
Interventional
Enrollment
100 (actual)
First submitted
24 Oct 2023
Start date
1 Jan 2024
Primary completion date
1 Apr 2024
Lead sponsor
MTI University
Diseases
Psoriasis
NCT number
NCT06106230

What you commit to

  • Study type: Interventional
  • Participants enrolled: 100
  • From 1 Jan 2024 to the primary completion date, 1 Apr 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Receiving steroid preparations
  • topical or UVB therapy within previous 4 wks
  • Systemic corticosteroids, PUVA, or laser phototherapy within previous 4 wks
  • Other systemic therapies or biologicals within previous 3 wks

Other illness

  • Patients with malignant tumors, those diagnosed with psoriatic arthritis or any other systemic inflammatory disease, or those using medication were excluded from the study.
  • Liver or renal disease

Other

  • Pregnancy
  • Widespread psoriasis
  • Hypercalcaemia

Who the study is looking for

  • Symmetrical mild-to-moderate chronic plaque psoriasis
  • Chronic stable plaque psoriasis
  • Bilateral lesions of approximately 25 cm²
  • Had not been receiving any treatment for at least one month.
  • Those with infection or malignancy and/or subjects who had undergone major surgery in the past 6 months were not included in the study.
  • Patients that had not undergone systemic treatment for psoriasis during the previous 3 months were included in the study
  • age 20 - 50 with mild to moderate knee plaque psoriasis
  • Symmetrical plaque psoriasis
  • PASI score affected \< 20
  • BSA of knee involvement : 2% to 20%

Age in the registry: 20 years to 50 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Ahmed Mohamed Ahmed Abdelhady
Coordinator of this site? Confirm its status
CairoEgyptUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.